Now Available at Pharmacies: Bayer's Finacea® Foam 15%

Bayer HealthCare’s Finacea^® (azelaic acid) Foam, 15% in now available at pharmacies nationwide. Finacea Foam was FDA approved in July 2015 for the topical treatment of the inflammatory papules and pustules of mild to moderate rosacea.

The approval was based on results from two pivotal clinical trials examining the efficacy and safety of Finacea^® Foam compared to its foam vehicle (without the drug azelaic acid) in the topical treatment of papulopustular rosacea.

Bayer is offering a prescription payment assistance program for patients who are prescribed Finacea^® Foam. The program includes a $0 initial co-pay for the first prescription (with a maximum benefit of $175) and significant savings on subsequent refills. For more information, log on to www.FinaceaFoam.com.